Insider: ROBINS HARLAN S Chief Scientific Officer - Adaptive Biotechnologies Corp
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,522,058 | 0 | 1,522,058 |
| Value | $22,541,678.98 | $0.00 | $22,541,678.98 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/11/2026 | DDS | 329,600 | Direct | COM | $13.17 | $4,340,832.00 | 1,522,058 |
| 03/11/2026 | DDS | 140,666 | Direct | COM | $13.17 | $1,852,571.22 | 1,851,658 |
| 03/03/2026 | DDS | 14,233 | Direct | COM | $16.52 | $235,129.16 | 1,155,291 |
| 03/02/2026 | DDS | 10,000 | Direct | COM | $15.72 | $157,200.00 | 1,169,524 |
| 02/03/2026 | DDS | 8,120 | Direct | COM | $19.00 | $154,280.00 | 1,179,524 |
| 02/02/2026 | DDS | 34,668 | Direct | COM | $18.60 | $644,824.80 | 1,187,644 |
| 01/06/2026 | DDS | 10,000 | Direct | COM | $16.44 | $164,400.00 | 1,222,312 |
| 12/04/2025 | DDS | 10,000 | Direct | COM | $16.61 | $166,100.00 | 1,232,312 |
| 12/03/2025 | DDS | 27,212 | Direct | COM | $18.61 | $506,415.32 | 1,242,312 |
| 11/10/2025 | DDS | 10,000 | Direct | COM | $14.82 | $148,200.00 | 1,269,524 |
| 05/01/2025 | DDS | 68,412 | Direct | COM | $7.35 | $502,828.20 | 1,279,524 |
| 03/24/2025 | DDS | 1,698 | Direct | COM | $9.00 | $15,282.00 | 1,279,524 |
| 03/05/2025 | DDS | 40,603 | Direct | COM | $6.98 | $283,408.94 | 1,335,577 |
| 03/05/2025 | DDS | 56,053 | Direct | COM | $6.99 | $391,810.47 | 1,279,524 |
| 03/07/2022 | DDS | 4,517 | Direct | COM | $12.01 | $54,249.17 | 311,960 |
| 11/18/2021 | DDS | 300 | Direct | COM | $31.36 | $9,408.00 | 69,360 |
| 11/17/2021 | DDS | 3,700 | Direct | COM | $32.05 | $118,585.00 | 69,360 |
| 10/21/2021 | DDS | 3,700 | Direct | COM | $33.73 | $124,801.00 | 69,360 |
| 10/20/2021 | DDS | 3,700 | Direct | COM | $33.71 | $124,727.00 | 69,360 |
| 10/19/2021 | DDS | 300 | Direct | COM | $32.91 | $9,873.00 | 72,860 |
| 10/19/2021 | DDS | 3,500 | Direct | COM | $33.76 | $118,160.00 | 69,360 |
| 10/08/2021 | DDS | 3,895 | Direct | COM | $32.96 | $128,379.20 | 69,360 |
| 10/07/2021 | DDS | 3,695 | Direct | COM | $33.68 | $124,447.60 | 69,360 |
| 10/07/2021 | DDS | 200 | Direct | COM | $32.50 | $6,500.00 | 73,055 |
| 10/06/2021 | DDS | 3,895 | Direct | COM | $32.27 | $125,691.65 | 69,360 |
| 1 2 3 4 5 6 Next Last You are at page 1 of 6 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research